Amy Garabedian
General Counsel bei LAVA THERAPEUTICS N.V.
Vermögen: 152 548 $ am 31.05.2024
Profil
Amy Garabedian is currently the Secretary & General Counsel at LAVA Therapeutics NV since 2021.
Prior to this, she worked as an Attorney at Ballard Spahr LLP.
From 2015 to 2020, she worked as an Associate General Counsel at Spark Therapeutics, Inc. Ms. Garabedian has a graduate degree from Temple University (Pennsylvania) and Widener University Delaware Law School, and an undergraduate degree from The Pennsylvania State University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
LAVA THERAPEUTICS NV
0,26% | 28.02.2023 | 67 499 ( 0,26% ) | 152 548 $ | 31.05.2024 |
Aktive Positionen von Amy Garabedian
Unternehmen | Position | Beginn |
---|---|---|
LAVA THERAPEUTICS N.V. | General Counsel | 27.07.2021 |
Ehemalige bekannte Positionen von Amy Garabedian
Unternehmen | Position | Ende |
---|---|---|
SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01.05.2020 |
Ballard Spahr LLP
Ballard Spahr LLP Miscellaneous Commercial ServicesCommercial Services Ballard Spahr LLP provides legal services. It also provides counsel in litigation, business and finance, real estate, intellectual property, and public finance. The company was founded in 1885 and is headquartered in Philadelphia, PA. | General Counsel | - |
Ausbildung von Amy Garabedian
The Pennsylvania State University | Undergraduate Degree |
Temple University (Pennsylvania) | Graduate Degree |
Widener University Delaware Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
LAVA THERAPEUTICS N.V. | Health Technology |
Private Unternehmen | 2 |
---|---|
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Ballard Spahr LLP
Ballard Spahr LLP Miscellaneous Commercial ServicesCommercial Services Ballard Spahr LLP provides legal services. It also provides counsel in litigation, business and finance, real estate, intellectual property, and public finance. The company was founded in 1885 and is headquartered in Philadelphia, PA. | Commercial Services |